Fundraising FoxMPM BioImpact — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
Photys Therapeutics, Inc.photys.cominSeries A · Sep 2022 · $75M✓ verified
Photys Therapeutics develops bifunctional small-molecule medicines that use induced proximity to recruit kinases and drive targeted protein phosphorylation, aiming to modulate and repair disease-driving proteins.
BiotechHealthtechLongevityWaltham, US
Amit Choudhary(Scientific Founder)David Steinberg(Chairman & Founding CEO)inEdward Holson(Co-founder & CSO)inLizzie Ngo(Co-founder)inBrian Fenton(President & CEO)in
Co-investorsLongwood Fund8VCMRL Ventures FundOno Venture Investment, Inc.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.